Glucose And Prostate Cancer Case Study

The majority of the studies done on the link between diet and cancer indicate that there is a relationship between high fat intake and an increased risk

A higher level of fats in the body puts the patient at higher risk for Cardiovascular diseases(CAD). The patient's' family has a history of CAD. Her mom and one of her sister have CAD (Lewis et al., 2014, pp. 733-734). The patient states that she has been taking her meds for cholesterol atorvastatin regularly. Her lipase level was 8272 on 11/11/16 and 2829 on 11/12/16 U/L 1069 on 11/13/16 (Ref range 73-393 U/L). Her HDL cholesterol level was 21 ( ref range>49 mg/dl), LDL Cholesterol level 148 ( ref range: <130 mg/dL). Patient statin drug was on hold because it is contradicted on the patient with an elevated level of ALT 80, 61(Ref range 0-50 U/L) and AST 61 on 11/12/16 and 64 on 11/13/16 (ref range 0-45 U/L). The uncontrolled level of could be the cause of concern for stroke or acute myocardial

Dr. Barbara Gower, Ph.D., says that the answer might be yes. A professor of nutrition sciences at the University of Alabama in Birmingham, Dr. Gower has just recently published the results to her study about the correlation between low-sugar and low-carbohydrate diet and cancer. Funded by the American Institute for Cancer Research, the study has yielded success stories of several women with ovarian cancer. After following the low-carb diet, these women’s cancer markers have dropped, along with their weight, blood pressure levels, and even body fat and visceral fat.

leading cause of cancer related mortality within the community for both men and women was

The Framingham study and others that followed showed us that HDL-cholesterol is an independent cardiovascular risk factor and that the increase of HDL-cholesterol of only 10 mg/dL leads to a risk reduction of 2-3% (PubMed.gov, Nov. 2012). Higher levels of HDL cholesterol result in a risk of cardiovascular disease closer to the default risk. Cardiovascular disease risk increases then plateaus with greater ratios between total cholesterol and HDL cholesterol. Thus, higher levels of HDL cholesterol proportionate to levels of total cholesterol relate to lower cardiovascular disease risk (Lecture #3). Having a HDL-cholesterol of 60 mg/dL and above is the best place for a person to be. A bit lower, but considered a good HDL-cholesterol level standing is 40-49 mg/dL for men and 50-59 mg/dL for women. All three of us, me, my mother, and the case study Danny are in good standing regarding HDL-cholesterol levels, my mother with 55 mg/dL, me with 50 mg/dL, and Danny with 40

of diabetes; 5 million cases of heart disease and more than 400, 000 different case of cancer

The risk factors for prostate cancer are normally a matter of age, race, and family history. It is somewhat out of your control. However, seeking medical advice and detecting the prostate cancer early is one important “man” strategy.

In a study conducted in 1985 observing primates, it was determined that the major effect of dietary cholesterol is its LDL raising effects. High intakes of cholesterol increase the number of circulating LDL’s and it can also change its size and composition. [12] It was during this time period that the mechanisms by which SFA are thought to increase blood cholesterol concentrations came about. One mechanism for the increase in LDL cholesterol levels is the suppression of LDL receptor activity. Studies in tissue cultures have shown that increasing the cholesterol content of a cell will down-regulate synthesis of LDL receptors. [13] This will lead to an increase in concentration of blood cholesterol. Another cause for an increase in blood cholesterol concentration through intake of dietary SFA is the composition of the newly secreted lipoproteins. With a high saturated fat intake, the LDL’s become rich in cholesterol esters, leaving the triglycerides in the blood. [14] The use of non-human primates in

Birt, D. F.; Pelling, J. C.; Nair, S., and Lepley, D. Diet intervention for modifying cancer risk. Prog Clin Biol Res. 1996; 395:223-34.

In trying to understand the differentials based on genetic factors, studies of the polymorphism Cyp3A4, which is important in androgen metabolism in prostate cancer, would have suggested that the presence of this polymorphism is a factor; however, the reality is that there wasn’t correlation with disease outcomes. In reality, the preponderance of all data suggests that there are no differences in outcomes based on race.

E.E. Calle, C. Rodriguez, K. Walker-Thurmond, et al. Overweight, obesity, and mortality from cancer in a prospectively studied cohort of U.S. adultsN. Engl. J. Med., 348 (2003), pp. 1625–1638

The underlying risk factors include obesity, physical inactivity and an atherogenic diet. The major risk factors for cardiovascular disease in this syndrome are smoking, hypertension, increased LDL cholesterol and low HDL cholesterol, aging and a family history of coronary events. The emerging risk factors are increased triglycerides, small LDL particles, insulin resistance, a pro inflammatory and prothrombotic state as well as glucose intolerance. The combination of these factors in one person is a predictor of that person having a future cardiovascular event or the onset of type 2 diabetes (Meigs, 2010). With so many risk factors laying down a set of defined parameters can be daunting. It is no wonder researchers often argue over set guidelines. However with more and more people developing these problems, it is necessary to start somewhere.

Furthermore, this article mentions the possible interplay between cancer and diabetes, which is a metabolic disease marked by high blood glucose level. Although it is still not certain if high blood glucose of diabetics have a higher cancer risk, it is clear in that tumors use glucose as their main source and more adept at extracting

Increased cholesterol levels, particularly low-density lipoprotein cholesterol (LDL-C), is one of the most potent CV risk factors. Epidemiological data show a continuous log-linear relationship between serum cholesterol levels and risk of CHD (Grundy et al. 2004). There are inconsistent reports of increased cholesterol levels in PD patients (Hayward et al. 1989; Tancer et al. 1990; Bajwa et al. 1992; Agargun et al. 1996; Shiori et al. 2000; Peter et al.

Prostate cancer is the second most common type of cancer diagnosed in men around the world today. Despite years of research, little is known as to the exact cause of prostate cancer, making it an area of intense research in medicine today. The pathology of prostate cancer has yielded important information on prevention, diagnosis and treatment methods. It has been understood that diet has much to do with tumour growth, and new research into nutrition is revealing new strategies in prostate cancer prevention. Genetics also play an important factor and must be taken into consideration. A number of new treatments for prostate cancer have been successfully implemented. Since prostate cancer is most common in men 50 and older, it is for the